0001209191-14-038032.txt : 20140530
0001209191-14-038032.hdr.sgml : 20140530
20140530165912
ACCESSION NUMBER: 0001209191-14-038032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140528
FILED AS OF DATE: 20140530
DATE AS OF CHANGE: 20140530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kherani Aftab
CENTRAL INDEX KEY: 0001584373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 14881069
MAIL ADDRESS:
STREET 1: C/O AISLING CAPITAL III, LP
STREET 2: 888 SEVENTH AVENUE, 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-05-28
0
0000876378
TRANSENTERIX INC.
TRXC
0001584373
Kherani Aftab
888 SEVENTH AVENUE, 30TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Stock Option
4.00
2014-05-28
4
A
0
20000
0.00
A
2024-05-28
Common Stock
20000
20000
D
Vests 25% per quarter on each quarterly anniversary of the date of grant with the final vesting on the first anniversary of the date of grant.
/s/Joshua Weingard, as Attorney-in-Fact for Aftab R. Kherani, M.D.
2014-05-30
EX-24.4_525534
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
For Executing Forms 3, 4 and 5
Know all persons by these presents, that the undersigned hereby constitutes and
appoints each of Joshua Weingard and Joseph P. Slattery, and each or either of
them, his true and lawful attorney-in-fact to:
(1) prepare and/or execute for and on behalf of the undersigned, in the
undersigned's capacity as a director of TransEnterix, Inc. (the "Company"),
Forms 3, 4 and 5 to report transactions in the Company's securities reportable
by the undersigned in accordance with the provisions of Section 16(a) of the
Securities Exchange Act of 1934, as amended and the rules and regulations
promulgated thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the preparation and execution of any
such Form 3, 4 or 5, and any amendment thereto, and the timely filing of any
such Form 3, 4 or 5, and any amendment thereto, with the United States
Securities and Exchange Commission and any other authority, it being understood
that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in his or
her discretion; and
(3) resign as attorney-in-fact and appoint, as a replacement attorney-in-fact,
any employee of the Company's legal or finance department at the time of such
resignation; provided that such resigning and replacement attorneys-in-fact
shall send notice to the undersigned of any such replacement.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or any
replacement attorney-in-fact, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, and any
replacement attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended or the rules and regulations promulgated
thereunder.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 30th of May, 2014.
/s/Aftab R. Kherani, M.D.
Signature
Aftab R. Kherani, M.D.
Print Name